CRClémence Rougeaux

Clémence Rougeaux

*This is an algorithmically generated author record based on publicly available information.

Clémence Rougeaux has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Development of an Innovative Galleria mellonella Model for Ricin Poisoning

    by Annabelle Garnier, Emilie Tessier, Arnaud Avril, Clémence Rougeaux

    Ricin is considered a chemical and biological weapon. It is found in the seeds of a plant, Ricinus communis. There are different isoforms of ricin with different levels of toxicity, depending on the R. communis plant. There is no current prophylaxis and specific treatment for ricin poisoning is recent. Assessing potential countermeasures against this toxin still relies on testing on vertebrate animal models. Galleria mellonella larva, already used for the testing of bacteria, viruses, and fungi, represents an alternative model that is more ethical, inexpensive, and easier to use. In this study, we demonstrated for the first time the sensitivity of G. mellonella larvae to different cultivars of ricin. We observed mortality and a reduction in health index scoring over the days of testing. The health index scoring was based on the survival, the melanization, the mobility, and the capacity of larvae to produce a cocoon or not. Mortality was cultivar- and dose-dependent. Mortality of G. mellonella larvae was reduced when they were treated with a monoclonal antibody and concomitantly injected with ricin. Thus, G. mellonella represents a rapid and simple model of ricin poisoning, and, more particularly, a relevant model to test new therapeutics against ricin.

  • Open Access

    Early Circulating Edema Factor in Inhalational Anthrax Infection: Does It Matter?

    by Emilie Tessier, Laurence Cheutin, Annabelle Garnier, Clarisse Vigne, Jean-Nicolas Tournier, Clémence Rougeaux

    Anthrax toxins are critical virulence factors of Bacillus anthracis and Bacillus cereus strains that cause anthrax-like disease, composed of a common binding factor, the protective antigen (PA), and two enzymatic proteins, lethal factor (LF) and edema factor (EF). While PA is required for endocytosis and activity of EF and LF, several studies showed that these enzymatic factors disseminate within the body in the absence of PA after intranasal infection. In an effort to understand the impact of EF in the absence of PA, we used a fluorescent EF chimera to facilitate the study of endocytosis in different cell lines. Unexpectedly, EF was found inside cells in the absence of PA and showed a pole-dependent endocytosis. However, looking at enzymatic activity, PA was still required for EF to induce an increase in intracellular cAMP levels. Interestingly, the sequential delivery of EF and then PA rescued the rise in cAMP levels, indicating that PA and EF may functionally associate during intracellular trafficking, as well as it did at the cell surface. Our data shed new light on EF trafficking and the potential location of PA and EF association for optimal cytosolic delivery.


  • Open Access

    Ricin Antibodies’ Neutralizing Capacity against Different Ricin Isoforms and Cultivars

    by Maria Lucia Orsini Delgado, Arnaud Avril, Julie Prigent, Julie Dano, Audrey Rouaix, Sylvia Worbs, Brigitte G. Dorner, Clémence Rougeaux, François Becher, François Fenaille, et al.

    Ricin, a highly toxic protein from Ricinus communis, is considered a potential biowarfare agent. Despite the many data available, no specific treatment has yet been approved. Due to their ability to provide immediate protection, antibodies (Abs) are an approach of choice. However, their high specificity might compromise their capacity to protect against the different ricin isoforms (D and E) found in the different cultivars. In previous work, we have shown the neutralizing potential of different Abs (43RCA-G1 (anti ricin A-chain) and RB34 and RB37 (anti ricin B-chain)) against ricin D. In this study, we evaluated their protective capacity against both ricin isoforms. We show that: (i) RB34 and RB37 recognize exclusively ricin D, whereas 43RCA-G1 recognizes both isoforms, (ii) their neutralizing capacity in vitro varies depending on the cultivar, and (iii) there is a synergistic effect when combining RB34 and 43RCA-G1. This effect is also demonstrated in vivo in a mouse model of intranasal intoxication with ricin D/E (1:1), where approximately 60% and 40% of mice treated 0 and 6 h after intoxication, respectively, are protected. Our results highlight the importance of evaluating the effectiveness of the Abs against different ricin isoforms to identify the treatment with the broadest spectrum neutralizing effect.


  • Open Access

    Anthrax Toxin Detection: From In Vivo Studies to Diagnostic Applications

    by Jean-Nicolas Tournier, Clémence Rougeaux

    Anthrax toxins are produced by Bacillus anthracis throughout infection and shape the physiopathogenesis of the disease. They are produced in low quantities but are highly efficient. They have thus been long ignored, but recent biochemical methods have improved our knowledge in animal models. This article reviews the various methods that have been used and how they could be applied to clinical diagnosis.


  • Open Access

    In vivo dynamics of active edema and lethal factors during anthrax

    by Clémence Rougeaux, François Becher, Eric Ezan, Jean-Nicolas Tournier, Pierre L. Goossens

    Lethal and edema toxins are critical virulence factors of Bacillus anthracis. However, little is known about their in vivo dynamics of production during anthrax. In this study, we unraveled for the first time the in vivo kinetics of production of the toxin components EF (edema factor) and LF (lethal factor) during cutaneous infection with a wild-type toxinogenic encapsulated strain in immuno-competent mice. We stratified the asynchronous infection process into defined stages through bioluminescence imaging (BLI), while exploiting sensitive quantitative methods by measuring the enzymatic activity of LF and EF. LF was produced in high amounts, while EF amounts steadily increased during the infectious process. This led to high LF/EF ratios throughout the infection, with variations between 50 to a few thousands. In the bloodstream, the early detection of active LF and EF despite the absence of bacteria suggests that they may exert long distance effects. Infection with a strain deficient in the protective antigen toxin component enabled to address its role in the diffusion of LF and EF within the host. Our data provide a picture of the in vivo complexity of the infectious process.